DK1808165T3 - Törre formuleringer af aripiprazol - Google Patents
Törre formuleringer af aripiprazolInfo
- Publication number
- DK1808165T3 DK1808165T3 DK06251325T DK06251325T DK1808165T3 DK 1808165 T3 DK1808165 T3 DK 1808165T3 DK 06251325 T DK06251325 T DK 06251325T DK 06251325 T DK06251325 T DK 06251325T DK 1808165 T3 DK1808165 T3 DK 1808165T3
- Authority
- DK
- Denmark
- Prior art keywords
- aripiprazole
- dry formulations
- tablets
- compositions
- dry compression
- Prior art date
Links
- CEUORZQYGODEFX-UHFFFAOYSA-N Aripirazole Chemical compound ClC1=CC=CC(N2CCN(CCCCOC=3C=C4NC(=O)CCC4=CC=3)CC2)=C1Cl CEUORZQYGODEFX-UHFFFAOYSA-N 0.000 title abstract 2
- 229960004372 aripiprazole Drugs 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 title abstract 2
- 238000009472 formulation Methods 0.000 title 1
- 230000006835 compression Effects 0.000 abstract 2
- 238000007906 compression Methods 0.000 abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
- A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US75670706P | 2006-01-05 | 2006-01-05 |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1808165T3 true DK1808165T3 (da) | 2009-08-03 |
Family
ID=36617397
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK06251325T DK1808165T3 (da) | 2006-01-05 | 2006-03-14 | Törre formuleringer af aripiprazol |
Country Status (14)
Country | Link |
---|---|
US (2) | US20070154545A1 (pt) |
EP (1) | EP1808165B1 (pt) |
JP (1) | JP2008531738A (pt) |
CN (1) | CN101351193A (pt) |
AT (1) | ATE429906T1 (pt) |
CA (1) | CA2627695A1 (pt) |
DE (1) | DE602006006536D1 (pt) |
DK (1) | DK1808165T3 (pt) |
ES (1) | ES2325219T3 (pt) |
HK (1) | HK1104795A1 (pt) |
IL (1) | IL190915A0 (pt) |
PL (1) | PL1808165T3 (pt) |
PT (1) | PT1808165E (pt) |
WO (1) | WO2007081367A1 (pt) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TR200604349A2 (tr) * | 2006-08-15 | 2008-03-21 | NOBEL İLAÇ SANAYii VE TiCARET A.Ş. | Aripiprazol içeren farmasötik bileşimler |
GB0618879D0 (en) | 2006-09-26 | 2006-11-01 | Zysis Ltd | Pharmaceutical compositions |
WO2010079506A2 (en) * | 2008-06-23 | 2010-07-15 | Torrent Pharmaceuticals Ltd. | Pharmaceutical composition of aripiprazole |
WO2011032882A1 (en) | 2009-09-15 | 2011-03-24 | Ratiopharm Gmbh | Orally disintegrating pharmaceutical dosage form containing aripiprazole |
TR201000948A1 (tr) * | 2010-02-09 | 2011-08-22 | Sanovel İlaç San.Ve Ti̇c.A.Ş. | Aripiprazol formülasyonları. |
CN103379901B (zh) * | 2010-11-30 | 2018-04-03 | 维斯塔实验室有限公司 | 含有氯化甲基息奥宁的配方 |
CN102850268B (zh) * | 2011-06-27 | 2015-07-15 | 上海中西制药有限公司 | 阿立哌唑ⅰ型微晶、阿立哌唑固体制剂及制备方法 |
WO2013175508A2 (en) | 2012-05-24 | 2013-11-28 | Medreich Limited | Stable pharmaceutical composition of aripiprazole |
US9051268B2 (en) | 2013-04-30 | 2015-06-09 | Otsuka Pharmaceutical Co., Ltd. | Oral solid preparation comprising aripiprazole and method for producing oral solid preparation comprising aripiprazole |
JP2016204260A (ja) * | 2013-10-04 | 2016-12-08 | 日本曹達株式会社 | 錠剤の製造方法 |
EP3065700A1 (en) * | 2013-11-07 | 2016-09-14 | Synthon B.V. | Orodispersible pharmaceutical compositions comprising aripiprazole |
CN106943405B (zh) * | 2016-01-06 | 2021-04-06 | 上海中西制药有限公司 | 一种阿立哌唑制剂及其制备方法 |
KR20190003805A (ko) * | 2016-05-27 | 2019-01-09 | 한미약품 주식회사 | 암 세포 성장을 저해하는 아민 유도체 또는 이의 약학적으로 허용가능한 염 및 저융점을 갖는 안정화제를 포함하는 약학적 조성물 |
CN108014343A (zh) * | 2017-12-21 | 2018-05-11 | 孟斯琴 | 一种治疗乳腺癌的药物组合物及其制备方法 |
CN111213650A (zh) * | 2020-02-25 | 2020-06-02 | 晋江市老君日化有限责任公司 | 一种蚊香的制备工艺 |
Family Cites Families (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2311734C (en) * | 2000-04-12 | 2011-03-08 | Bristol-Myers Squibb Company | Flash-melt oral dosage formulation |
MY129350A (en) * | 2001-04-25 | 2007-03-30 | Bristol Myers Squibb Co | Aripiprazole oral solution |
AR033485A1 (es) * | 2001-09-25 | 2003-12-26 | Otsuka Pharma Co Ltd | Sustancia medicinal de aripiprazol de baja higroscopicidad y proceso para la preparacion de la misma |
TWI324074B (en) * | 2001-10-09 | 2010-05-01 | Bristol Myers Squibb Co | Flashmelt oral dosage formulation |
JP2003238393A (ja) * | 2002-02-15 | 2003-08-27 | Otsuka Pharmaceut Co Ltd | 施錠性が改善された錠剤及びその製造方法 |
DE10224170A1 (de) * | 2002-05-31 | 2003-12-11 | Desitin Arzneimittel Gmbh | Pharmazeutische Zusammensetzung mit verzögerter Wirkstofffreisetzung |
WO2004083183A1 (en) * | 2003-03-21 | 2004-09-30 | Hetero Drugs Limited | Novel crystalline forms of aripiprazole |
EP1618103A2 (en) * | 2003-04-25 | 2006-01-25 | Cadila Healthcare Ltd. | Polymorphs of aripiprazole |
BRPI0415531B8 (pt) * | 2003-10-23 | 2021-05-25 | Otsuka Pharma Co Ltd | formulação de aripiprazol injetável estéril de liberação controlada e método para a sua preparação |
ATE529409T1 (de) * | 2003-12-16 | 2011-11-15 | Teva Pharma | Verfahren zur herstellung von kristallinen aripiprazolformen |
US7507823B2 (en) * | 2004-05-06 | 2009-03-24 | Bristol-Myers Squibb Company | Process of making aripiprazole particles |
CN102627603A (zh) * | 2004-11-18 | 2012-08-08 | 斯索恩有限公司 | 制备结晶阿立哌唑的方法 |
EP1812396A1 (en) * | 2004-11-18 | 2007-08-01 | Synthon B.V. | Crystalline aripiprazole solvates |
EP1686117A1 (en) * | 2005-01-27 | 2006-08-02 | Sandoz AG | Polymorph and solvates of aripiprazole |
ES2526415T3 (es) * | 2005-03-17 | 2015-01-12 | Synthon B.V. | Comprimidos farmacéuticos de aripiprazol cristalino de tipo II |
AU2006247482A1 (en) * | 2005-05-13 | 2006-11-23 | Lexicon Pharmaceuticals, Inc. | Multicyclic compounds and methods of their use |
US20070014853A1 (en) * | 2005-07-15 | 2007-01-18 | Ilan Zalit | Pharmaceutical dosage form containing novel pharmaceutical granulate |
US20070014854A1 (en) * | 2005-07-15 | 2007-01-18 | Ilan Zalit | Novel granulation process |
US20070014864A1 (en) * | 2005-07-15 | 2007-01-18 | Teva Pharmaceutical Industries, Ltd. | Novel pharmaceutical granulate |
CA2622758A1 (en) * | 2005-09-15 | 2007-03-29 | Elan Pharma International, Limited | Nanoparticulate aripiprazole formulations |
JP2008537540A (ja) * | 2005-12-22 | 2008-09-18 | テバ ファーマシューティカル インダストリーズ リミティド | アリピプラゾールの粒径を小さくする方法 |
US20070148245A1 (en) * | 2005-12-22 | 2007-06-28 | Ilan Zalit | Compressed solid dosage forms with drugs of low solubility and process for making the same |
EP1880714A1 (en) * | 2006-07-20 | 2008-01-23 | Helm AG | Amorphous Aripiprazole and Process for the Preparation thereof |
-
2006
- 2006-03-14 AT AT06251325T patent/ATE429906T1/de not_active IP Right Cessation
- 2006-03-14 PT PT06251325T patent/PT1808165E/pt unknown
- 2006-03-14 ES ES06251325T patent/ES2325219T3/es active Active
- 2006-03-14 PL PL06251325T patent/PL1808165T3/pl unknown
- 2006-03-14 CA CA002627695A patent/CA2627695A1/en not_active Abandoned
- 2006-03-14 DK DK06251325T patent/DK1808165T3/da active
- 2006-03-14 DE DE602006006536T patent/DE602006006536D1/de active Active
- 2006-03-14 CN CNA200680050282XA patent/CN101351193A/zh active Pending
- 2006-03-14 JP JP2007558353A patent/JP2008531738A/ja active Pending
- 2006-03-14 EP EP06251325A patent/EP1808165B1/en not_active Revoked
- 2006-03-14 US US11/376,472 patent/US20070154545A1/en not_active Abandoned
- 2006-03-14 WO PCT/US2006/009280 patent/WO2007081367A1/en active Application Filing
-
2007
- 2007-12-05 HK HK07113266.3A patent/HK1104795A1/xx not_active IP Right Cessation
-
2008
- 2008-04-16 IL IL190915A patent/IL190915A0/en unknown
-
2013
- 2013-06-19 US US13/921,713 patent/US20130344146A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
JP2008531738A (ja) | 2008-08-14 |
DE602006006536D1 (de) | 2009-06-10 |
WO2007081367A1 (en) | 2007-07-19 |
ATE429906T1 (de) | 2009-05-15 |
US20070154545A1 (en) | 2007-07-05 |
HK1104795A1 (en) | 2008-01-25 |
ES2325219T3 (es) | 2009-08-28 |
CN101351193A (zh) | 2009-01-21 |
US20130344146A1 (en) | 2013-12-26 |
EP1808165B1 (en) | 2009-04-29 |
EP1808165A1 (en) | 2007-07-18 |
PT1808165E (pt) | 2009-06-09 |
IL190915A0 (en) | 2008-11-03 |
CA2627695A1 (en) | 2007-07-19 |
PL1808165T3 (pl) | 2009-09-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1808165T3 (da) | Törre formuleringer af aripiprazol | |
ATE528989T1 (de) | Kristalline feste rasagilin-base | |
DK1808164T3 (da) | Vådgranuleringsmetode til fremstilling af farmaceutiske sammensætninger af aripiprazol | |
PH12015500550A1 (en) | Anti-notch1 nrr antibodies and methods using same | |
IL193074A0 (en) | Stable pharmaceutical formulations of montelukast sodium | |
WO2008121767A3 (en) | Stitched polypeptides | |
UY30225A1 (es) | Composiciones farmacéuticas | |
DK3219705T3 (da) | Farmaceutiske sammensætninger af den amorfe form af n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinolin-3-carboxamid | |
IL204844A (en) | Coinolone analogues, pharmaceuticals containing them and their uses | |
WO2007127834A3 (en) | Compositions and methods of preparation thereof | |
WO2007109604A3 (en) | Pharmaceutical compositions | |
ATE526318T1 (de) | Farnesoid-x-rezeptor-agonisten | |
BRPI0511900A (pt) | composições farmacêuticas | |
IL195488A (en) | Compounds, pharmaceuticals containing them and their uses | |
BRPI0913379A2 (pt) | formulações farmacêuticas sólidas compreendendo bibw 2992 | |
WO2008057550A3 (en) | Stabilization of vaccines by lyophilization | |
EA200601596A1 (ru) | Улучшенный состав 6-меркаптопурина | |
CL2007001838A1 (es) | Compuestos derivados de 4-oxoquinolina; composicion farmaceutica; y uso del compuesto para la produccion de un agente anti-vih. | |
WO2006091836A8 (en) | Formulations of ladostigil tartrate | |
BRPI0812234A2 (pt) | Composto de quinolona e composição farmacêutica. | |
WO2007087026A3 (en) | Solid-state form of amg 706 and pharmaceutical compositions thereof | |
FR2923834B1 (fr) | Nouvelles compositions polysicocyanates hydrodispersibles. | |
BRPI0614413A2 (pt) | composto, e, composição farmacêutica | |
EA200600590A1 (ru) | Фармацевтические композиции модафинила с модифицированным высвобождением | |
BRPI0614412A2 (pt) | composto, e, composição farmacêutica |